Tapewire

Nasdaq · USD

CRNX

Crinetics Pharmaceuticals, Inc.

Export transactions ↓
Tapewire entity
3579
SEC CIK
0001658247
Parsed reports
316

Last 12 months

Inside the activity.

0 purchase rows · 18 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202501
Jan 202601
Feb 202600
Mar 2026010
Apr 202601
May 202600
Jun 202602
Jul 202601
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 07, 2024 Filed Jun 11, 2024 20:20 UTC GrantCommon Stock 3,400 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-071928 · ownership.xml · nonDerivative · entry 1

Okey Stephanie · CIK 0001742616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,400

F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:21 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $44.71 $0.00
Disclosure

SEC source: 0000950170-24-071930 · ownership.xml · derivative · entry 2

Vivaldi Coelho Rogerio · CIK 0001610381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2034-06-07

F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:21 UTC GrantCommon Stock 3,400 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-071930 · ownership.xml · nonDerivative · entry 1

Vivaldi Coelho Rogerio · CIK 0001610381 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,400

F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:20 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $44.71 $0.00
Disclosure

SEC source: 0000950170-24-071926 · ownership.xml · derivative · entry 2

Nichols Weston · CIK 0001746376 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2034-06-07

F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:20 UTC GrantCommon Stock 3,400 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-071926 · ownership.xml · nonDerivative · entry 1

Nichols Weston · CIK 0001746376 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,400

F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:19 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $44.71 $0.00
Disclosure

SEC source: 0000950170-24-071923 · ownership.xml · derivative · entry 2

Bedrosian Camille L · CIK 0001326969 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2034-06-07

F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:19 UTC GrantCommon Stock 3,400 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-071923 · ownership.xml · nonDerivative · entry 1

Bedrosian Camille L · CIK 0001326969 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,400

F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:19 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $44.71 $0.00
Disclosure

SEC source: 0000950170-24-071924 · ownership.xml · derivative · entry 2

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2034-06-07

F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:19 UTC GrantCommon Stock 3,400 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-071924 · ownership.xml · nonDerivative · entry 1

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,936

F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:18 UTC GrantStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $44.71 $0.00
Disclosure

SEC source: 0000950170-24-071921 · ownership.xml · derivative · entry 2

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,500

Underlying: Common Stock · 12,500 shares

Expires 2034-06-07

F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
June 07, 2024 Filed Jun 11, 2024 20:18 UTC GrantCommon Stock 3,400 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-071921 · ownership.xml · nonDerivative · entry 1

WIERENGA WENDALL · CIK 0001235945 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,246

F1 · price: The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 100% vesting on the earlier of the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
May 28, 2024 Filed May 30, 2024 20:28 UTC
Betz Stephen F.Chief Scientific Officer
SaleCommon Stock 3,000 $47.49 $142,470.00
Disclosure

SEC source: 0000950170-24-066657 · ownership.xml · nonDerivative · entry 1

Betz Stephen F. · CIK 0001886575 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,643

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $47.49 per share. The range of sales prices on the transaction date was $47.24 to $48.01 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
May 10, 2024 Filed May 14, 2024 22:29 UTC
Betz Stephen F.Chief Scientific Officer
SaleCommon Stock 3,000 $49.43 $148,290.00
Disclosure

SEC source: 0000950170-24-059865 · ownership.xml · nonDerivative · entry 1

Betz Stephen F. · CIK 0001886575 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 89,643

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:57 UTC
Struthers Richard ScottDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 107,448 $0.00 Strike: $9.28 $0.00
Disclosure

SEC source: 0000950170-24-057926 · ownership.xml · derivative · entry 8

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,342

Underlying: Common Stock · 107,448 shares

Expires 2028-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:57 UTC
Struthers Richard ScottDirector · President & CEO
SaleCommon Stock 107,448 $49.40 $5,307,931.20
Disclosure

SEC source: 0000950170-24-057926 · ownership.xml · nonDerivative · entry 2

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 257,485

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan entered into in March 2023.

F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $49.40 per share. The range of sales prices on the transaction date was $48.95 to $50.15 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
May 08, 2024 Filed May 10, 2024 20:57 UTC
Struthers Richard ScottDirector · President & CEO
Exercise / conversionCommon Stock 107,448 $9.28 $997,117.44
Disclosure

SEC source: 0000950170-24-057926 · ownership.xml · nonDerivative · entry 1

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 364,933

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 18, 2024 Filed Apr 22, 2024 21:23 UTC
Struthers Richard ScottDirector · President & CEO
GiftCommon Stock 350 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-046523 · ownership.xml · nonDerivative · entry 1

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,485

F1 · kind: Bona fide gift made by the Reporting Person for no consideration.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 16:36 UTC
Pizzuti DanaChief Med and Dev Officer
Exercise / conversionStock option (Right to Buy) · Derivative 14,375 $0.00 Strike: $16.89 $0.00
Disclosure

SEC source: 0000950170-24-045142 · ownership.xml · derivative · entry 3

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,292

Underlying: Common Stock · 14,375 shares

Expires 2032-10-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option is exercisable as follows: 25% of the shares subject to the option vest on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 16:36 UTC
Pizzuti DanaChief Med and Dev Officer
SaleCommon Stock 14,375 $44.47 $639,256.25
Disclosure

SEC source: 0000950170-24-045142 · ownership.xml · nonDerivative · entry 2

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 27,786

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $44.47 per share. The range of sales prices on the transaction date was $43.98 to $44.75 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 16:36 UTC
Pizzuti DanaChief Med and Dev Officer
Exercise / conversionCommon Stock 14,375 $16.89 $242,793.75
Disclosure

SEC source: 0000950170-24-045142 · ownership.xml · nonDerivative · entry 1

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 42,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 20:30 UTC
Struthers Richard ScottDirector · President & CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $1.91 $0.00
Disclosure

SEC source: 0000950170-24-045136 · ownership.xml · derivative · entry 7

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,270

Underlying: Common Stock · 20,000 shares

Expires 2028-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: 1/48th of the shares subject to the option vested on April 16, 2018, and 1/48th of the shares subject to the option vest monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
April 15, 2024 Filed Apr 17, 2024 20:30 UTC
Struthers Richard ScottDirector · President & CEO
Exercise / conversionCommon Stock 20,000 $1.91 $38,200.00
Disclosure

SEC source: 0000950170-24-045136 · ownership.xml · nonDerivative · entry 1

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 257,835

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 21:09 UTC
Struthers Richard ScottDirector · President & CEO
Exercise / conversionNon-qualified stock option (Right to Buy) · Derivative 40,951 $0.00 Strike: $9.28 $0.00
Disclosure

SEC source: 0000950170-24-042681 · ownership.xml · derivative · entry 8

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,790

Underlying: Common Stock · 40,951 shares

Expires 2028-05-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: 1/48th of the shares subject to the option vested on June 25, 2018, and 1/48th of the shares subject to the option vested monthly thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 21:09 UTC
Struthers Richard ScottDirector · President & CEO
SaleCommon Stock 40,951 $49.17 $2,013,560.67
Disclosure

SEC source: 0000950170-24-042681 · ownership.xml · nonDerivative · entry 2

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 237,835

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan.

F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $49.17 per share. The range of sales prices on the transaction date was $48.95 to $49.56 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
April 04, 2024 Filed Apr 8, 2024 21:09 UTC
Struthers Richard ScottDirector · President & CEO
Exercise / conversionCommon Stock 40,951 $9.28 $380,025.28
Disclosure

SEC source: 0000950170-24-042681 · ownership.xml · nonDerivative · entry 1

Struthers Richard Scott · CIK 0001746298 · Director · President & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 278,786

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 28, 2024 Filed Apr 2, 2024 20:35 UTC Exercise / conversionStock Option (right to buy) · Derivative 17,500 $0.00 Strike: $18.29 $0.00
Disclosure

SEC source: 0001209191-24-005184 · doc4.xml · derivative · entry 3

Okey Stephanie · CIK 0001742616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,500 shares

Expires 2032-06-17

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
March 28, 2024 Filed Apr 2, 2024 20:35 UTC SaleCommon Stock 17,500 $46.38 $811,650.00
Disclosure

SEC source: 0001209191-24-005184 · doc4.xml · nonDerivative · entry 2

Okey Stephanie · CIK 0001742616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,000

F1 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $46.38 per share. The range of sales prices on the transaction date was $46.06 to $46.66 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
March 28, 2024 Filed Apr 2, 2024 20:35 UTC Exercise / conversionCommon Stock 17,500 $18.29 $320,075.00
Disclosure

SEC source: 0001209191-24-005184 · doc4.xml · nonDerivative · entry 1

Okey Stephanie · CIK 0001742616 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 22, 2024 Filed Mar 26, 2024 20:30 UTC
Knight Jeff E.Chief Operating Officer
Exercise / conversionStock Option (right to buy) · Derivative 30,000 $0.00 Strike: $23.98 $0.00
Disclosure

SEC source: 0001209191-24-005081 · doc4.xml · derivative · entry 4

Knight Jeff E. · CIK 0001881007 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 30,000 shares

Expires 2031-09-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is exercisable as follows: 25% of the shares subject to the option vest on August 30, 2022, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
March 22, 2024 Filed Mar 26, 2024 20:30 UTC
Knight Jeff E.Chief Operating Officer
SaleCommon Stock 2,359 $45.39 $107,075.01
Disclosure

SEC source: 0001209191-24-005081 · doc4.xml · nonDerivative · entry 3

Knight Jeff E. · CIK 0001881007 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 52,580

Read SEC document
March 22, 2024 Filed Mar 26, 2024 20:30 UTC
Knight Jeff E.Chief Operating Officer
SaleCommon Stock 30,000 $44.22 $1,326,600.00
Disclosure

SEC source: 0001209191-24-005081 · doc4.xml · nonDerivative · entry 2

Knight Jeff E. · CIK 0001881007 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,939

F1 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $44.22 per share. The range of sales prices on the transaction date was $44.00 to $44.52 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
March 22, 2024 Filed Mar 26, 2024 20:30 UTC
Knight Jeff E.Chief Operating Officer
Exercise / conversionCommon Stock 30,000 $23.98 $719,400.00
Disclosure

SEC source: 0001209191-24-005081 · doc4.xml · nonDerivative · entry 1

Knight Jeff E. · CIK 0001881007 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,939

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 16:52 UTC
Pizzuti DanaChief Med and Dev Officer
Exercise / conversionStock Option (right to buy) · Derivative 10,000 $0.00 Strike: $16.89 $0.00
Disclosure

SEC source: 0001209191-24-005061 · doc4.xml · derivative · entry 7

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 191,667

Underlying: Common Stock · 10,000 shares

Expires 2032-10-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is exercisable as follows: 25% of the shares subject to the option vest on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 16:52 UTC
Pizzuti DanaChief Med and Dev Officer
Exercise / conversionStock Option (right to buy) · Derivative 4,375 $0.00 Strike: $16.89 $0.00
Disclosure

SEC source: 0001209191-24-005061 · doc4.xml · derivative · entry 6

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,667

Underlying: Common Stock · 4,375 shares

Expires 2032-10-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option is exercisable as follows: 25% of the shares subject to the option vest on September 30, 2023, and the remaining number of shares subject to the option vest monthly thereafter in thirty-six equal monthly installments, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 16:52 UTC
Pizzuti DanaChief Med and Dev Officer
SaleCommon Stock 714 $43.69 $31,194.66
Disclosure

SEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 5

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,786

Read SEC document
March 20, 2024 Filed Mar 22, 2024 16:52 UTC
Pizzuti DanaChief Med and Dev Officer
SaleCommon Stock 10,000 $43.28 $432,800.00
Disclosure

SEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 4

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

F1 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.28 per share. The range of sales prices on the transaction date was $42.70 to $43.77 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 16:52 UTC
Pizzuti DanaChief Med and Dev Officer
Exercise / conversionCommon Stock 10,000 $16.89 $168,900.00
Disclosure

SEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 3

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 16:52 UTC
Pizzuti DanaChief Med and Dev Officer
SaleCommon Stock 4,375 $45.89 $200,768.75
Disclosure

SEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 2

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,500

Read SEC document
March 20, 2024 Filed Mar 22, 2024 16:52 UTC
Pizzuti DanaChief Med and Dev Officer
Exercise / conversionCommon Stock 4,375 $16.89 $73,893.75
Disclosure

SEC source: 0001209191-24-005061 · doc4.xml · nonDerivative · entry 1

Pizzuti Dana · CIK 0001948238 · Chief Med and Dev Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,875

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC Exercise / conversionStock Option (right to buy) · Derivative 17,500 $0.00 Strike: $18.29 $0.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · derivative · entry 12

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,500 shares

Expires 2032-06-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC Exercise / conversionStock Option (right to buy) · Derivative 17,500 $0.00 Strike: $20.23 $0.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · derivative · entry 11

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 17,500 shares

Expires 2031-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC Exercise / conversionStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $23.23 $0.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · derivative · entry 10

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2030-06-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC Exercise / conversionStock Option (right to buy) · Derivative 12,500 $0.00 Strike: $23.24 $0.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · derivative · entry 9

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 12,500 shares

Expires 2029-06-20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option shall vest and become exercisable on the earlier of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC SaleCommon Stock 17,500 $45.50 $796,250.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 8

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,536

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC Exercise / conversionCommon Stock 17,500 $18.29 $320,075.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 7

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC SaleCommon Stock 17,500 $43.58 $762,650.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 6

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,536

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.58 per share. The range of sales prices on the transaction date was $42.70 to $44.23 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC Exercise / conversionCommon Stock 17,500 $20.23 $354,025.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 5

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC SaleCommon Stock 12,500 $43.57 $544,625.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 4

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,536

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.57 per share. The range of sales prices on the transaction date was $42.70 to $44.23 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC Exercise / conversionCommon Stock 12,500 $23.23 $290,375.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 3

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 31,036

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 20, 2024 Filed Mar 22, 2024 20:31 UTC SaleCommon Stock 12,500 $43.57 $544,625.00
Disclosure

SEC source: 0001209191-24-005060 · doc4.xml · nonDerivative · entry 2

Fust Matthew K · CIK 0001397266 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 18,536

F1 · kind: The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $43.57 per share. The range of sales prices on the transaction date was $42.70 to $44.23 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.